ScholarGate
Asistenti

Opioid Use Disorder

Opioid use disorder is a substance use disorder arising from problematic use of opioids — including heroin and prescription analgesics such as morphine, oxycodone, and fentanyl. It is diagnosed using the same general criteria applied across substance classes and is notable clinically for a well-defined withdrawal syndrome and for elevated overdose mortality.

Gjeni temë me PaperMindSë shpejtiFind papers & topics
Tools & resources
Shkarko diapozitivat
Learn & explore
VideoSë shpejti

Definition

Opioid use disorder is a problematic pattern of opioid use leading to clinically significant impairment or distress, diagnosed by the standard substance use disorder criteria and frequently accompanied by tolerance and a characteristic withdrawal syndrome on cessation.

Scope

The entry covers how opioid use disorder is defined and classified, the pharmacology of opioids relevant to tolerance and withdrawal, and its epidemiologic significance. It is a reference and educational overview; it describes the disorder and the evidence base around it but does not provide dosing, diagnostic thresholds for an individual, or treatment instructions.

Core questions

  • How is opioid use disorder classified within addiction nosology?
  • What pharmacological features distinguish opioids in relation to tolerance, withdrawal, and overdose?
  • What is the epidemiologic and public-health significance of the disorder?

Key concepts

  • Mu-opioid receptor agonism
  • Tolerance
  • Opioid withdrawal syndrome
  • Overdose and respiratory depression
  • Heroin and prescription opioids
  • Fentanyl and synthetic opioids

Key theories

Brain disease model applied to opioids
A framework in which repeated opioid exposure produces neuroadaptations in reward and stress circuitry that underlie tolerance, withdrawal, and compulsive use, supporting the classification of opioid use disorder as a chronic medical condition.

Mechanisms

Opioids act chiefly as agonists at the mu-opioid receptor, producing analgesia, euphoria, and respiratory depression. Repeated use drives neuroadaptation, manifesting as tolerance (diminished effect at a given exposure) and, on cessation, a withdrawal syndrome. Within the brain disease model, these adaptations in reward and anti-reward circuitry are linked to the impaired control and continued use that define the disorder. Respiratory depression at high exposure underlies the overdose risk that distinguishes opioids epidemiologically from many other substance classes.

Clinical relevance

Opioid use disorder is a leading cause of substance-related morbidity and mortality, and recognizing its classification and natural history is central to addiction medicine and public health. This entry is educational reference material; it characterizes the disorder and its evidence base and does not provide diagnostic cut-offs for individuals or any treatment or dosing guidance.

Epidemiology

Opioid dependence is a substantial contributor to the global burden of disease attributable to illicit drug use, and the disorder carries a markedly elevated risk of premature death, driven in recent years by potent synthetic opioids such as fentanyl in some regions.

Evidence & guidelines

Opioid use disorder is defined within DSM-5 (American Psychiatric Association, 2013) and ICD-11. Narrative reviews by Schuckit (2016) and Blanco and Volkow (2019) summarize its clinical features and the evidence base for its management at a descriptive level.

History

Opioid dependence has been recognized clinically for over a century, but its formal classification evolved with the broader nosology of substance use disorders, moving from the abuse/dependence distinction of DSM-IV to the single graded opioid use disorder of DSM-5 (2013). The emergence of widespread prescription-opioid and later synthetic-opioid problems reshaped the disorder's epidemiology and public-health profile.

Debates

Tolerance and withdrawal in patients on prescribed opioids
Because physiological tolerance and withdrawal can occur with appropriately prescribed opioid therapy, DSM-5 notes that these pharmacological criteria are not counted toward a diagnosis when opioids are taken solely under medical supervision, a distinction that affects case definition.

Key figures

  • Marc Schuckit
  • Nora Volkow
  • Carlos Blanco

Related topics

Seminal works

  • schuckit-2016
  • blanco-2019
  • apa-dsm5-2013

Frequently asked questions

What opioids are involved in opioid use disorder?
They include illicit opioids such as heroin and pharmaceutical opioids such as morphine, oxycodone, hydrocodone, and fentanyl; the disorder is defined by the pattern of problematic use rather than by a specific drug.
Why is opioid use disorder associated with overdose?
Opioids cause dose-related respiratory depression, so high or combined exposures — especially involving potent synthetic opioids — can be fatal, which is why overdose mortality is a defining public-health feature of the disorder.

Methods for this concept

Related concepts